ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Recurrent Acute Lymphoblastic Leukemia · Recurrent Acute Myeloid Leukemia · Recurrent Myelodysplastic Syndrome · Refractory Acute Lymphoblastic Leukemia · Refractory Acute Myeloid Leukemia · Refractory Myelodysplastic Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
M D Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Gautam Borthakur)
Study leads
Gautam Borthakur
Principal Investigator
M.D. Anderson Cancer Center